Cargando…

Target product profile: aerosolized surfactant for neonatal respiratory distress

Treatment with surfactant has been found to improve the survival rate of neonates with respiratory distress syndrome, particularly preterm infants. However, surfactant is usually administered by endotracheal intubation and generally only in level-3 neonatal intensive care units. Recent improvements...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rao, Suman, Edmond, Karen, Bahl, Rajiv
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Health Organization 2023
Materias:	Policy & Practice
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140689/ https://www.ncbi.nlm.nih.gov/pubmed/37131945 http://dx.doi.org/10.2471/BLT.23.289727

Ejemplares similares

Target product profile for readers of rapid diagnostic tests
por: White, Wallace, et al.
Publicado: (2023)

WHO target product profiles to shape global research and development
por: Charnaud, Sarah C, et al.
Publicado: (2023)

Target product profile: diagnostic test for Trypanosoma brucei gambiense
por: Priotto, Gerardo, et al.
Publicado: (2023)

Target product profile: diagnostic test for Trypanosoma brucei rhodesiense
por: Priotto, Gerardo, et al.
Publicado: (2023)

Target product profiles: tests for tuberculosis treatment monitoring and optimization
por: Gupta-Wright, Ankur, et al.
Publicado: (2023)

Target product profile: Trypanosoma brucei gambiense test to verify elimination
por: Priotto, Gerardo, et al.
Publicado: (2023)

Aerosol Delivery of Lung Surfactant and Nasal CPAP in the Treatment of Neonatal Respiratory Distress Syndrome
por: Walther, Frans J., et al.
Publicado: (2022)

Target product profile: Trypanosoma brucei gambiense test for low-prevalence settings
por: Priotto, Gerardo, et al.
Publicado: (2023)

Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
por: Brasher, Mandy, et al.
Publicado: (2021)

Antibiotics needed to treat multidrug-resistant infections in neonates
por: Williams, Phoebe CM, et al.
Publicado: (2022)

Aerosol, chemical and physical properties of dry powder synthetic lung surfactant for noninvasive treatment of neonatal respiratory distress syndrome
por: Walther, Frans J., et al.
Publicado: (2021)

Attribute-centred theorizing to address behavioural changes
por: Rimal, Rajiv N, et al.
Publicado: (2021)

Prehospital administration of surfactant to a premature neonate in respiratory distress
por: Mize, Charles Haviland, et al.
Publicado: (2019)

Irrational prescription of surfactant replacement therapy in neonatal respiratory distress
por: Jahanmehr, Nader, et al.
Publicado: (2022)

Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection
por: Fitzner, Julia, et al.
Publicado: (2018)

Regulatory evaluation of biosimilars throughout their product life-cycle
por: Kang, Hye-Na, et al.
Publicado: (2018)

Modelling the global economic costs of tobacco product waste
por: Lam, Juleen, et al.
Publicado: (2022)

Pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome
por: Guo, Hongxing, et al.
Publicado: (2023)

Linking health and finance ministries to improve taxes on unhealthy products
por: Siu, Erika, et al.
Publicado: (2022)

Fractional-dose inactivated poliovirus vaccine, India
por: Haldar, Pradeep, et al.
Publicado: (2019)

Tuberculosis control in China: use of modelling to develop targets and policies
por: Lin, Hsien-Ho, et al.
Publicado: (2015)

Progress achieved in restricting the marketing of high-fat, sugary and salty food and beverage products to children
por: Kraak, Vivica I, et al.
Publicado: (2016)

Control of sexually transmitted infections and global elimination targets, South-East Asia Region
por: Sharma, Mukta, et al.
Publicado: (2021)

Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress
por: Tarocco, Anna, et al.
Publicado: (2015)

Turkish Neonatal Society guideline on the management of respiratory distress syndrome and surfactant treatment
por: Özkan, Hasan, et al.
Publicado: (2018)

History of Pulmonary Surfactant Replacement Therapy for Neonatal Respiratory Distress Syndrome in Korea
por: Bae, Chong-Woo, et al.
Publicado: (2019)

The Role of Surfactant in Respiratory Distress Syndrome
por: Ma, Christopher Cheng-Hwa, et al.
Publicado: (2012)

Corrigendum to “Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress”
por: Tarocco, Anna, et al.
Publicado: (2015)

Priority-setting for achieving universal health coverage
por: Chalkidou, Kalipso, et al.
Publicado: (2016)

Surfactant replacement therapy for non-respiratory distress syndrome neonatal respiratory disease —research or clinical application?
por: Greenough, Anne
Publicado: (1995)

Violence against children during the COVID-19 pandemic
por: Bhatia, Amiya, et al.
Publicado: (2021)

Effect of different ventilation methods combined with pulmonary surfactant on neonatal acute respiratory distress syndrome
por: Qing, Qing, et al.
Publicado: (2023)

Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials
por: Logan, J Wells, et al.
Publicado: (2009)

Correlation between surfactant protein B mRNA expression and neonatal respiratory distress syndrome
por: YIN, XIAOJUAN, et al.
Publicado: (2012)

Continuous positive pressure ventilation combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome
por: Miao, Jing, et al.
Publicado: (2020)

Goat lung surfactant for treatment of respiratory distress syndrome among preterm neonates: a multi-site randomized non-inferiority trial
por: Jain, Kajal, et al.
Publicado: (2019)

A Proposed Target Product Profile and Developmental Cascade for New Cryptosporidiosis Treatments
por: Huston, Christopher D., et al.
Publicado: (2015)

Riverine food environments and food security: a case study of the Mekong River, Cambodia
por: Manohar, Swetha, et al.
Publicado: (2023)

Poliovirus surveillance in patients with primary immunodeficiencies, India
por: Mohanty, Madhu Chhanda, et al.
Publicado: (2023)

New global indicator for workers’ health: mortality rate from diseases attributable to selected occupational risk factors
por: Pega, Frank, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qjtqehbps3b4onttd7g1joj3pi